Stock listing
NASDAQ:OSIR Osiris Therapeutics Inc Stock
Follow Osiris Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:OSIR
$18.99 USD
Close on Apr 16, 2019 · No longer trades
- Lowest – highest close
- $3.86 – $28.56 USDSince Aug 9, 2006 · lowest Mar 13, 2017 · highest Jan 12, 2007
Delisted NASDAQ:OSIR no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:OSIR
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Linda Palczuk Other companies: Avadel Pharmaceuticals PLC (Director · Since at least Jul 18, 2018); Verrica Pharmaceuticals Inc. (Chief Operating Officer · Jun 14, 2018 – Feb 28, 2019 · Past) | President & CEO · Jul 10, 2017 – Jul 10, 2017 · Past |
| C. Randal Mills Other companies: Elutia, Inc. (President & CEO · Since at least Oct 7, 2020) | President & CEO, Director · Aug 3, 2006 – Dec 3, 2013 · Past |
| David L White Other companies: Choice Hotels International, Inc. (Senior Vice President · Feb 9, 2006 – Apr 15, 2016 · Past) | Director · May 30, 2017 – May 30, 2017 · Past |
| Gregory Hurd Barnhill Other companies: PURE Bioscience (Director · Apr 12, 2006 – Jul 31, 2012 · Past) | Director · Aug 3, 2006 – Mar 23, 2012 · Past |
| Jonathan Mark Hopper Other companies: Vericel Corporation (Chief Medical Officer · Since at least Feb 11, 2020) | Chief Medical Officer · Nov 24, 2014 – Apr 12, 2016 · Past |
| Michelle Williams Other companies: Elutia, Inc. (Chief Scientific Officer · Since at least Aug 22, 2022) | Chief Scientific Officer · May 1, 2007 – Apr 14, 2014 · Past |
| Shauna L Vernal Other companies: Inovalon Holdings Inc (Fmr. Chief Legal Officer · Feb 11, 2015 – Jan 23, 2018 · Past) | Chiel Legal Officer · Mar 6, 2018 – Mar 6, 2018 · Past |
| Adrian Patrick Mollo | General Counsel · Nov 19, 2014 – Nov 19, 2014 · Past |
| Alla Danilkovitch | Chief Scientific Officer · Apr 9, 2015 – Apr 17, 2019 · Past |
| Earl R Fender | Vice President · Aug 3, 2006 – Feb 4, 2008 · Past |
All 23 people
| Person | Seat |
|---|---|
| Felix Gutzwiller | Director · Mar 23, 2012 – Feb 6, 2014 · Past |
| Frank D Czworka Jr | Vice President · Mar 9, 2016 – Mar 9, 2016 · Past |
| Hans-Georg Klingemann | Director · Sep 19, 2012 – Feb 6, 2014 · Past |
| Harry E Carmitchel | Chief Operating Officer · Aug 3, 2006 – Dec 8, 2008 · Past |
| Jason Keefer | Chief Commercial Officer · Jun 21, 2017 – Apr 17, 2019 · Past |
| Joel David Rogers | Interim CFO · May 9, 2018 – May 9, 2018 · Past |
| Lode Debrabandere | President & CEO · Aug 3, 2006 – Feb 22, 2016 · Past |
| Matthew Paul Neumayer | Principal Accounting Officer · Nov 6, 2009 – Sep 30, 2014 · Past |
| Peter Friedli | Director · Aug 3, 2006 – Apr 17, 2019 · Past |
| Rodrigo Alberto Avendano | Chief Medical Officer · Oct 3, 2016 – Jan 27, 2017 · Past |
| Samson Tom | President & CEO · Nov 26, 2018 – Nov 26, 2018 · Past |
| Uwe Sommer | Director · Feb 7, 2017 – Feb 7, 2017 · Past |
| Willi Miesch | Director · Feb 6, 2018 – Feb 6, 2018 · Past |
Log in to ask 6ix AI your own questions about Osiris Therapeutics Inc.